Summit on revolution in personalised medicine caused by molecular
30 January 2008
Recent advances in genetic knowledge are transforming
molecular imaging, molecular diagnostics and informatics to create
stunningly precise diagnostic tools capable of assessing and treating a
growing number of critical diseases.
These new diagnostic tools provide physicians with an understanding of
individual patient or disease differences at the molecular or genetic level,
enabling them to leverage predictive diagnosis and tailor effective
treatment to the individual.
The Dark Report, a business intelligence
service for the clinical laboratory industry and pathologists, and Siemens
have assembled an international faculty of experts and early adopters of
integrated diagnostic care pathways within radiology and pathology to
address the first international Molecular Summit on the integration of in
vivo and in vitro diagnostics. The Summit will be held in Philadelphia, USA
on 5-6 Feb, 2008.
About the Summit
The conference sessions will
show how innovators are advancing clinical care and enhancing their
financial strength by incorporating the latest molecular imaging techniques
in tandem with emerging molecular diagnostics. Industry pioneers will speak
about evolving changes in R&D, the discovery of new medicines, effective
policies to translate these discoveries into better outcomes for patients,
resulting treatments that improve healthcare, and new business strategies to
advance the field of personalized medicine. Continuing Education Units
(CEU's) are provided by the American Association of Clinical Chemistry
To address this new frontier in healthcare, Thomas Miller, CEO of
Siemens Healthcare's Workflow and Solutions Division, will serve as a
keynote speaker at the first international Molecular Summit on the
integration of in vivo and in vitro diagnostics on February 5-6, 2008, at
the Sheraton Society Hill Hotel in Philadelphia.
Miller will discuss
Siemens' vision for a new era in medicine, one enabled through integration
of molecular imaging, molecular diagnostics and informatics, specifically
how the integration of these disciplines will lead to predictive diagnosis
and individualized treatment — true personalized medicine, which will result
in improved patient outcomes. Additionally, he will speak about Siemens'
business strategy for becoming the world's first and pre-eminent leader in
in vivo and in vitro diagnostics
"Healthcare is evolving, entering a new
era, one created through the marriage of in vivo and in vitro diagnostics,
arming clinicians with the tools that enable early intervention and
treatment in a way that improves clinical efficiencies, effectiveness and
outcomes," said Thomas Miller, CEO, Workflow and Solutions Division, Siemens
"We are ushering in the era of personalized medicine, moving the practice
of medicine from the disease-centric to the knowledge-driven,
patient-centric approach. For all of us who care passionately about this —
pathologists, radiologists and healthcare IT executives — the Summit will
deliver the latest information defining the next generation of integrated
diagnostic and clinical services."
The Molecular Summit will feature case
studies involving the delivery of molecular imaging and molecular
diagnostics services, particularly where collaboration is occurring between
radiology, pathology, and informatics to integrate molecular imaging with
relevant molecular diagnostics services.
"Alert physicians involved in
imaging and molecular diagnostics know these technology advances are already
breaking down traditional specialty silos," said Robert L. Michel, editor,
The Dark Report. "The Molecular Summit brings together early adopters who
will share their practical experiences and discuss emerging opportunities."
Case studies and presentations will illustrate new technology, effective use
of informatics to support molecular imaging and molecular diagnostics, and
new developments in the way clinicians use these technologies.
The Summit will also feature highlights of molecular diagnostics
implemented in clinical laboratories, imaging centres, pathology groups,
radiology groups, hospitals, and health systems.
Speakers will deliver strategic presentations on how healthcare and
diagnostic medicine will utilize molecular technologies in imaging,
diagnostics and informatics in the future, and industry experts will conduct
strategic assessments of the growing field of molecular medicine, identify
emerging trends, and discuss how government and private payers are likely to
respond with new coverage guidelines and reimbursement levels.
More information about the event can be found at